Theratechnologies Inc. Dropped from S&P Global BMI Index
ByAinvest
Friday, Sep 26, 2025 9:55 am ET1min read
THTX--
Theratechnologies Inc. is a Canada-based biopharmaceutical company focused on developing therapies for HIV, NASH, and oncology. Their products include Trogarzo, a long-acting monoclonal antibody for HIV, and EGRIFTA SV, for reducing excess abdominal fat in HIV patients with lipodystrophy. The company is also conducting Phase I clinical trials for sudocetaxel zendusortide in advanced ovarian cancer.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet